Combined use of ecteinascidin-743 and platinum antineoplastic compounds

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20070128201A1
SERIAL NO

10558133

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

ET-743 can be used to mitigate resistance to and potentiate the cytotoxic effects of a platinum coordination complex anti-neoplastic agent in a human cancer patient.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PHARMA MAR S A UMADRID

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
D'Incalci, Maurizio Milan, IT 9 75
Donaque, Jose Maria Jimeno Madrid, ES 4 54
Gianni, Luca Milan, IT 16 201
Giavazzi, Raffaella Milan, IT 2 20
Judson, Ian London, GB 1 15
Martin, Margarita Garcia Barcelona, ES 1 15
Sessa, Cristiana Bellinzona, CH 2 15

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation